Close Menu

hereditary cancer

The agency has described detailed situations under which it will cover BRCA testing and multi-gene panels for assessing risk for hereditary cancer syndromes.

The company attributed its third quarter revenue decline to bad weather.

The privately-held German firm also plans to offer genetic tumor profiling and noninvasive prenatal testing.

The deal between the firms grants Quest the rights to use Genomic Vision's technology to develop tests for breast and ovarian cancer, among other diseases.

The research also uncovered other mutations that might be associated with these cancers in patients who do not have a CDH1 mutation.

In addition to the drop in revenues, Myriad lowered its FY 2015 revenue guidance.

Invitae has received accreditation for its laboratory from the College of American Pathologists as well as coverage eligibility from Blue Shield of California and the Centers for Medicare and Medicaid Services.

Data presented at AMP compares clinical performance of InVitae's next-generation sequencing-based hereditary cancer risk test compared to BRCA1/2 testing alone.

Genetic testing laboratory Pathway Genomics today announced a partnership with the Prospective Registry of Multiplex Testing, an online registry for patients who have undergone testing for cancer-causing genetic mutations. Pathway Genomics will provide information about the registry to patients and healthcare providers receiving panel tests.

NEW YORK (GenomeWeb) – While industry observers might disagree about whether GeneDx's decision to apply for inter partes review (IPR) of 11 patents held by Myriad Genetics will work in its favor, they generally concur that it is a quicker and less costly strategy than litigation.

Pages

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.